$Novo-Nordisk A/S(NVO)$ view o

$Novo-Nordisk A/S(NVO)$ view order details.@Trade Feed Decoder

NVO

07-29 19:41

USNovo-Nordisk A/S

Side	Price \| Filled	Realized P&L
Buy Open	53.50 30	-5.90% Holding

Novo-Nordisk A/S

Trade Feed: Who is your favorite trader?

Come to the Trade Feed Topic to find more trading opportunities! Also, please feel free to recommend and introduce fellow Tigers to the "hidden gem traders" that you've discovered!

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Trade Feed Decoder
07-29
Trade Feed Decoder
This Novo Nordisk (NVO) trade shows a modest 1.31% gain, suggesting a short-term tactical play given the pharmaceutical sector's typical lower volatility. While the entry price aligns with historical support levels around Q2 2023, the timestamp appears anomalous (future date), warranting verification of trade chronology. The execution likely capitalized on NVO's stable performance in diabetes/Ozempic markets, though the position size isn't disclosed - a critical factor given biopharma's binary event risks. The profit margin aligns with intraday swing trading strategies rather than long-term holding patterns. Traders might study how macroeconomic factors like drug pricing policies or clinical trial updates influenced this entry timing, while noting that single-day gains in large caps often require precise technical triggers given their liquidity-driven price action.

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":461910646182672,"tweetId":"461910646182672","gmtCreate":1753789344305,"gmtModify":1754968840027,"author":{"id":3563840597970088,"idStr":"3563840597970088","authorId":3563840597970088,"authorIdStr":"3563840597970088","name":"SGEmployee","avatar":"https://static.tigerbbs.com/1eb6228d831d940a6110ce973ddd8935","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":12,"crmLevelSwitch":0,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-2","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Executive Tiger","description":"The transaction amount of the securities account reaches $300,000","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.44%","individualDisplayEnabled":0},"individualDisplayBadges":[],"fanSize":25,"starInvestorFlag":true,"fullDisclosureFlag":true,"starInvestorFollowerNum":25,"starInvestorOrderShareNum":57,"userFollowInvestorFlag":false,"orderNotificationFlag":false,"ror":56.23,"showRor":true,"winRationPercentage":59.42623,"tradeVolumeEst":0},"themes":[{"themeId":"4e1ab37448a24dd39b7882426fc6fd27","categoryId":"ab3d937a5fd848c08008411a9be702b5","name":"Trade Feed: Who is your favorite trader?","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":4e1ab37448a24dd39b7882426fc6fd27}&rnconfig={\"headerBarHidden\": true}","description":"Come to the Trade Feed Topic to find more trading opportunities! Also, please feel free to recommend and introduce fellow Tigers to the \"hidden gem traders\" that you've discovered!","image":"https://community-static.tradeup.com/news/e496e574dd744490c7b4f7959f83f5a4"}],"images":[],"coverImages":[],"html":"<html><head></head><body><a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$&nbsp;</a>view order details.<a href=\"https://ttm.financial/U/10000000000011061\">@Trade Feed Decoder</a></body></html>","htmlText":"<html><head></head><body><a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$&nbsp;</a>view order details.<a href=\"https://ttm.financial/U/10000000000011061\">@Trade Feed Decoder</a></body></html>","text":"$Novo-Nordisk A/S(NVO)$ view order details.@Trade Feed Decoder","highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":1,"favoriteSize":0,"link":"https://ttm.financial/post/461910646182672","repostId":0,"isVote":1,"tweetType":1,"viewCount":282,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["NVO"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":true,"orderData":{"uuid":"3563840597970088","orderId":"39962556192526336","kind":"TRADE","symbol":"NVO","secType":"STK","symbolHtmlTag":"<a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$&nbsp;</a>","symbolHtmlTagHref":"https://ttm.financial/S/NVO","symbolName":"Novo-Nordisk A/S","market":"US","action":"BUY","currency":"USD","symbolLogo":"https://static.tigerbbs.com/4454e2be594d73a2a7bfa9c42bfb69f7","showFilledQuantity":true,"nameCN":"Novo-Nordisk A/S","orderType":"LMT","filledQuantityFinal":30,"avgFillPrice":53.5,"createTime":1753789308,"filledQuantity":"30","filledQuantityScale":"0","openFlag":true,"side":"DEBIT","contractMajorDescription":"Novo-Nordisk A/S","contractExtraDescription":"NVO","legs":[],"completedFlag":false,"orderPnl":{"openRealizedPnlPercent":0,"openUnrealizedPnlPercent":-0.059},"quickOrderFlag":false},"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":["订单分享帖","未分享订单分享帖"],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":34,"optionInvolvedFlag":false,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":461834737942952,"commentId":"461834737942952","gmtCreate":1753794639018,"gmtModify":1753795185785,"authorId":10000000000011060,"author":{"id":10000000000011060,"idStr":"10000000000011061","authorId":10000000000011060,"name":"Trade Feed Decoder","avatar":"https://community-static.tradeup.com/news/4dc8fec78bad5acffbf563bdbc6bc8ed","vip":4,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":461910646182672,"objectIdStr":"461910646182672","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"This Novo Nordisk (NVO) trade shows a modest 1.31% gain, suggesting a short-term tactical play given the pharmaceutical sector's typical lower volatility. While the entry price aligns with historical support levels around Q2 2023, the timestamp appears anomalous (future date), warranting verification of trade chronology. The execution likely capitalized on NVO's stable performance in diabetes/Ozempic markets, though the position size isn't disclosed - a critical factor given biopharma's binary event risks. The profit margin aligns with intraday swing trading strategies rather than long-term holding patterns. Traders might study how macroeconomic factors like drug pricing policies or clinical trial updates influenced this entry timing, while noting that single-day gains in large caps often require precise technical triggers given their liquidity-driven price action.","text":"This Novo Nordisk (NVO) trade shows a modest 1.31% gain, suggesting a short-term tactical play given the pharmaceutical sector's typical lower volatility. While the entry price aligns with historical support levels around Q2 2023, the timestamp appears anomalous (future date), warranting verification of trade chronology. The execution likely capitalized on NVO's stable performance in diabetes/Ozempic markets, though the position size isn't disclosed - a critical factor given biopharma's binary event risks. The profit margin aligns with intraday swing trading strategies rather than long-term holding patterns. Traders might study how macroeconomic factors like drug pricing policies or clinical trial updates influenced this entry timing, while noting that single-day gains in large caps often require precise technical triggers given their liquidity-driven price action.","html":"This Novo Nordisk (NVO) trade shows a modest 1.31% gain, suggesting a short-term tactical play given the pharmaceutical sector's typical lower volatility. While the entry price aligns with historical support levels around Q2 2023, the timestamp appears anomalous (future date), warranting verification of trade chronology. The execution likely capitalized on NVO's stable performance in diabetes/Ozempic markets, though the position size isn't disclosed - a critical factor given biopharma's binary event risks. The profit margin aligns with intraday swing trading strategies rather than long-term holding patterns. Traders might study how macroeconomic factors like drug pricing policies or clinical trial updates influenced this entry timing, while noting that single-day gains in large caps often require precise technical triggers given their liquidity-driven price action.","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"hot","coins":0,"score":0,"disclaimerFlag":true,"disclaimerType":1,"specialCommentTag":"AI_ANALYSE"}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/461910646182672"}